Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
Cancer metastasis is the leading cause of death in patients, here, the authors show disrupting tumor vasculature could recruit and activate anti-PD-L1 engineered platelet at metastatic tumor sites to block the PD-1/PD-L1 crosstalk and enhance the anticancer immunotherapy.
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/608a4349715044a79d78a3f8c89aa2c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:608a4349715044a79d78a3f8c89aa2c6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:608a4349715044a79d78a3f8c89aa2c62021-12-02T16:50:26ZDisrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis10.1038/s41467-021-22674-32041-1723https://doaj.org/article/608a4349715044a79d78a3f8c89aa2c62021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-22674-3https://doaj.org/toc/2041-1723Cancer metastasis is the leading cause of death in patients, here, the authors show disrupting tumor vasculature could recruit and activate anti-PD-L1 engineered platelet at metastatic tumor sites to block the PD-1/PD-L1 crosstalk and enhance the anticancer immunotherapy.Hongjun LiZejun WangZhaowei ChenTianyuan CiGuojun ChenDi WenRuoxin LiJinqiang WangHuan MengR. Bryan BellZhifeng GuGianpietro DottiZhen GuNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Hongjun Li Zejun Wang Zhaowei Chen Tianyuan Ci Guojun Chen Di Wen Ruoxin Li Jinqiang Wang Huan Meng R. Bryan Bell Zhifeng Gu Gianpietro Dotti Zhen Gu Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis |
description |
Cancer metastasis is the leading cause of death in patients, here, the authors show disrupting tumor vasculature could recruit and activate anti-PD-L1 engineered platelet at metastatic tumor sites to block the PD-1/PD-L1 crosstalk and enhance the anticancer immunotherapy. |
format |
article |
author |
Hongjun Li Zejun Wang Zhaowei Chen Tianyuan Ci Guojun Chen Di Wen Ruoxin Li Jinqiang Wang Huan Meng R. Bryan Bell Zhifeng Gu Gianpietro Dotti Zhen Gu |
author_facet |
Hongjun Li Zejun Wang Zhaowei Chen Tianyuan Ci Guojun Chen Di Wen Ruoxin Li Jinqiang Wang Huan Meng R. Bryan Bell Zhifeng Gu Gianpietro Dotti Zhen Gu |
author_sort |
Hongjun Li |
title |
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis |
title_short |
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis |
title_full |
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis |
title_fullStr |
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis |
title_full_unstemmed |
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis |
title_sort |
disrupting tumour vasculature and recruitment of apdl1-loaded platelets control tumour metastasis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/608a4349715044a79d78a3f8c89aa2c6 |
work_keys_str_mv |
AT hongjunli disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT zejunwang disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT zhaoweichen disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT tianyuanci disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT guojunchen disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT diwen disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT ruoxinli disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT jinqiangwang disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT huanmeng disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT rbryanbell disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT zhifenggu disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT gianpietrodotti disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis AT zhengu disruptingtumourvasculatureandrecruitmentofapdl1loadedplateletscontroltumourmetastasis |
_version_ |
1718383039997804544 |